Financière de Tubize company profile
Company profile
Financière de Tubize has 3 employees and is headquartered in Brussels, Belgium.
A stake in UCB, a biopharmaceutical company in Belgium, forms the core of the activity of Financière de Tubize SA. Through this holding, the company is linked to research into medicines aimed at people with illnesses that affect the immune system or the central nervous system. Founded in 1928, it is based in Brussels, Belgium, and its shareholding is the basis of its business.
In the fiscal year ended 31 December 2025, Financière de Tubize SA reported a net profit of 93.2 million euros. No revenue figure is available for the same period. The company has 3 employees, and its accounts are expressed in euros. Its headquarters are located in Brussels.
Company facts
- Sector
- Finance
- Industry
- Biotechnology
- Country
- Belgium
- Headquarters
- Allée de la Recherche 60, 1070, Brussels
- Employees
- 3
- Chief executive
- Eric Nys
- Founded
- 1928
- Fiscal year
- January - December
- Listing
- TUB · Euronext Brussels
- Currency
- EUR
- ISIN
- BE0003823409
- Website
- financiere-tubize.be
Financière de Tubize and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | ROE | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Financière de TubizeTUB | Belgium | $11.78B | 3 | 5.0% | 109.0 |
| ALK-AbellóALK.B | Denmark | $8.09B | 2,773 | 21.2% | 40.7 |
| ABIVAXABVX | France | $7.61B | 98 | -252.3% | — |
| Bachem HoldingBANB | Switzerland | $6.92B | 2,725 | 10.6% | 39.2 |
| GenmabGMAB | Denmark | $31.53B | 3,244 | 12.1% | 46.2 |
| CamurusCAMX | Sweden | $4.36B | 323 | 16.6% | 58.5 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
